NEW YORK (GenomeWeb) – To increase the chance of pregnancy and reduce the incidence of miscarriage, more and more fertility clinics have started using preimplantation genetic screening (PGS) to test embryos resulting from in vitro fertilization for chromosomal abnormalities before they are transferred to a woman's uterus.

In most cases, the test yields a clear-cut result: the embryo is either euploid or aneuploid, and transferring a euploid embryo enhances the rate of pregnancy, lowers the risk of miscarriage, and decreases the chance of having a baby with a birth defect.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.